REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/28/2026
Back to search
Official data from USPTO
APPLIED BIOMATH REVOLUTIONIZING DRUG INVENTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
03/01/2026
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
11/02/2015
Registration date
02/28/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2022
Last transaction
03/01/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
08/08/2014
First use in commerce
08/08/2014
Drawing code
3
Owner type
16
Owner location
Concord, MA, US
Examiner
PINO, BRIAN
Law office
M50
Current location
TMO LAW OFFICE 114
Mark description
The mark consists of on the left side a design element consisting of a circle, within which are two ovals overlapping on a diagonal axis; to the right of the design are the words "applied biomath" in lowercase lettering, and below the "applied biomath" appears the words "revolutionizing drug invention" in uppercase lettering.
Holders and representatives
Holders
Applied Biomath, LLC
Applied Biomath, LLC
Representatives
Carrie Webb Olson Day Pitney LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Pharmaceutical drug development services; Pharmaceutical research services; Scientific and technological servicescomputational analysis in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
52 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/09/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/09/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/09/2024
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
09/26/2023
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
08/18/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/13/2023
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/25/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/27/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/27/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/27/2022
E815
TEAS SECTION 8 & 15 RECEIVED
03/30/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/28/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/12/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/28/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/13/2016
PUBO
PUBLISHED FOR OPPOSITION
12/13/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/30/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/30/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/23/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/01/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/01/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/15/2016
GNFR
FINAL REFUSAL E-MAILED
09/15/2016
CNFR
FINAL REFUSAL WRITTEN
09/15/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/03/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/02/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/23/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/23/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/02/2016
GNRT
NON-FINAL ACTION E-MAILED
03/02/2016
CNRT
NON-FINAL ACTION WRITTEN
03/02/2016
DOCK
ASSIGNED TO EXAMINER
02/24/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/07/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2015
NWAP
NEW APPLICATION ENTERED
11/05/2015
Continuous trademark protection
Get notified about every new filing that threatens APPLIED BIOMATH REVOLUTIONIZING DRUG INVENTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.